Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Capital Leases (2019 - 2023)

Serina Therapeutics (SER) has disclosed Capital Leases for 2 consecutive years, with $1000.0 as the latest value for Q4 2023.

  • Quarterly Capital Leases changed N/A to $1000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $1000.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $1000.0 for FY2023, N/A changed from the prior year.
  • Capital Leases hit $1000.0 in Q4 2023 for Serina Therapeutics, down from $221000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $221000.0 in Q2 2019 to a low of $1000.0 in Q4 2023.